These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 22105061)
1. Comparison of buprenorphine treatment for opioid dependence in 3 settings. Miotto K; Hillhouse M; Donovick R; Cunningham-Rathner J; Charuvastra C; Torrington M; Esagoff AE; Ling W J Addict Med; 2012 Mar; 6(1):68-76. PubMed ID: 22105061 [TBL] [Abstract][Full Text] [Related]
2. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. Fiellin DA; Pantalon MV; Chawarski MC; Moore BA; Sullivan LE; O'Connor PG; Schottenfeld RS N Engl J Med; 2006 Jul; 355(4):365-74. PubMed ID: 16870915 [TBL] [Abstract][Full Text] [Related]
3. Use of conventional, complementary, and alternative treatments for pain among individuals seeking primary care treatment with buprenorphine-naloxone. Barry DT; Savant JD; Beitel M; Cutter CJ; Moore BA; Schottenfeld RS; Fiellin DA J Addict Med; 2012 Dec; 6(4):274-9. PubMed ID: 23041680 [TBL] [Abstract][Full Text] [Related]
4. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Weiss RD; Potter JS; Fiellin DA; Byrne M; Connery HS; Dickinson W; Gardin J; Griffin ML; Gourevitch MN; Haller DL; Hasson AL; Huang Z; Jacobs P; Kosinski AS; Lindblad R; McCance-Katz EF; Provost SE; Selzer J; Somoza EC; Sonne SC; Ling W Arch Gen Psychiatry; 2011 Dec; 68(12):1238-46. PubMed ID: 22065255 [TBL] [Abstract][Full Text] [Related]
5. Accessing opiate dependence treatment medications: buprenorphine products in an office-based setting. Leshner AI Drug Alcohol Depend; 2003 May; 70(2 Suppl):S103-4. PubMed ID: 12738354 [No Abstract] [Full Text] [Related]
6. Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults. Gonzalez G; DiGirolamo G; Romero-Gonzalez M; Smelson D; Ziedonis D; Kolodziej M Drug Alcohol Depend; 2015 Nov; 156():243-253. PubMed ID: 26454835 [TBL] [Abstract][Full Text] [Related]
7. The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence. Mammen K; Bell J Expert Opin Pharmacother; 2009 Oct; 10(15):2537-44. PubMed ID: 19708849 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial. Webster L; Hjelmström P; Sumner M; Gunderson EW J Addict Dis; 2016; 35(4):325-338. PubMed ID: 27267785 [TBL] [Abstract][Full Text] [Related]
9. Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience. Amass L; Ling W; Freese TE; Reiber C; Annon JJ; Cohen AJ; McCarty D; Reid MS; Brown LS; Clark C; Ziedonis DM; Krejci J; Stine S; Winhusen T; Brigham G; Babcock D; Muir JA; Buchan BJ; Horton T Am J Addict; 2004; 13 Suppl 1(Suppl 1):S42-66. PubMed ID: 15204675 [TBL] [Abstract][Full Text] [Related]
10. Association of Counseling and Psychotherapy on Retention in Medication for Addiction Treatment Within a Large Medicaid Population. Eren K; Schuster J; Herschell A; Loveland D; Neimark G; Mihalyo M; Hurford M; Houck P; Ryan N J Addict Med; 2022 May-Jun 01; 16(3):346-353. PubMed ID: 34561351 [TBL] [Abstract][Full Text] [Related]
11. Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology. Mooney LJ; Nielsen S; Saxon A; Hillhouse M; Thomas C; Hasson A; Stablein D; McCormack J; Lindblad R; Ling W Contemp Clin Trials; 2013 Mar; 34(2):196-204. PubMed ID: 23159524 [TBL] [Abstract][Full Text] [Related]
12. Drugs approved for opiate dependence. FDA Consum; 2003; 37(1):6. PubMed ID: 12625293 [No Abstract] [Full Text] [Related]
13. Comparison of behavioral treatment conditions in buprenorphine maintenance. Ling W; Hillhouse M; Ang A; Jenkins J; Fahey J Addiction; 2013 Oct; 108(10):1788-98. PubMed ID: 23734858 [TBL] [Abstract][Full Text] [Related]
14. Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment. Mokri A; Chawarski MC; Taherinakhost H; Schottenfeld RS Addiction; 2016 May; 111(5):874-82. PubMed ID: 26639678 [TBL] [Abstract][Full Text] [Related]
15. Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population. McDermott KA; Griffin ML; Connery HS; Hilario EY; Fiellin DA; Fitzmaurice GM; Weiss RD J Clin Psychiatry; 2015 Feb; 76(2):189-94. PubMed ID: 25562462 [TBL] [Abstract][Full Text] [Related]
16. Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy. Soyka M; Hillemacher T Addiction; 2014 Jan; 109(1):88-9. PubMed ID: 24438113 [No Abstract] [Full Text] [Related]
17. Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines. Balhara YP J Opioid Manag; 2013; 9(4):237. PubMed ID: 24380101 [No Abstract] [Full Text] [Related]
18. Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial. Lintzeris N; Dunlop AJ; Haber PS; Lubman DI; Graham R; Hutchinson S; Arunogiri S; Hayes V; Hjelmström P; Svedberg A; Peterson S; Tiberg F JAMA Netw Open; 2021 May; 4(5):e219041. PubMed ID: 33970256 [TBL] [Abstract][Full Text] [Related]
19. From research to the real world: buprenorphine in the decade of the Clinical Trials Network. Ling W; Jacobs P; Hillhouse M; Hasson A; Thomas C; Freese T; Sparenborg S; McCarty D; Weiss R; Saxon A; Cohen A; Straus M; Brigham G; Liu D; McLaughlin P; Tai B J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S53-60. PubMed ID: 20307796 [TBL] [Abstract][Full Text] [Related]
20. Inpatient initiation of buprenorphine maintenance vs. detoxification: can retention of opioid-dependent patients in outpatient counseling be improved? Caldiero RM; Parran TV; Adelman CL; Piche B Am J Addict; 2006; 15(1):1-7. PubMed ID: 16449087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]